Genetic testing revealed a novel heterozygous mutation in the <i>NPRL3</i> gene.<h4>Discussion</h4>This case highlights the diagnostic challenges of SHE and the importance of genetic testing in drug-resistant epilepsy. Here, NPRL3 is linked to sleep-related hypermotor epilepsy.